King-Denborough Syndrome: Report of a Family

Authors

DOI:

https://doi.org/10.46531/sinapse/CC/230040/2023

Keywords:

Abnormalities, Multiple/ diagnosis, Malignant Hyperthermia, Neuromuscular Diseases/ diagnosis, Ryanodine Receptor Calcium Release Channel/genetics, Syndrome

Abstract

We report a case of an Azorean family with the diagnosis of the King-Denborough syndrome. Both mother and the two siblings present all the characteristic clinical findings of this syndrome – facial dysmorphias (with palpebral ptosis, malar hypoplasia, arched palate and micrognathia), musculoskeletal abnormalities (bell-shaped chest, pectus excavatum and lumbar hyperlordosis), diminished lower limbs strength with associated hyporeflexia and susceptibility to malignant hyperthermia. The diagnosis was possible after the youngest member of the family, now a 4-year-old girl, was born and referred to in-hospital consultation, due to the described constellation of dysmorphias and delay in motor development. The aim of this article is to raise awareness to the importance of the correct investigation approach of a congenital myopathy, and in this specific case, to the importance of an early diagnosis that can be crucial to prevent a mostly fatal outcome for these patients.

Downloads

Download data is not yet available.

References

- Reed UC, Resende MB, Ferreira LG, Carvalho MS, Diament A, Scaff M, Marie SK. King-Denborough Syndrome: report of two Brazilian cases. Arq Neuropsiquiatr. 2002;60:739-41. doi: 10.1590/s0004-282x2002000500011.

- Dowling JJ, Lillis S, Amburgey K, Zhou H, Al-Sarraj S, Buk SJ, et al. King-Denborough syndrome with and without mutations in the skeletal muscle ryanodine receptor (RYR1) gene. Neuromuscul Disord. 2011;21:420-7. doi: 10.1016/j.nmd.2011.03.006.

- D’Arcy CE, Bjorksten A, Yiu EM, Bankier A, Gillies R, McLean CA, Shield LK, Ryan MM. King-denborough syndrome caused by a novel mutation in the ryanodine receptor gene. Neurology. 2008;71:776-7. doi: 10.1212/01.wnl.0000324929.33780.2f.

- McPherson EW, Taylor CA Jr. The King syndrome: malignant hyperthermia, myopathy, and multiple anomalies. Am J Med Genet. 1981;8:159-65. doi: 10.1002/ajmg.1320080206.

- Lawal TA, Todd JJ, Meilleur KG. Ryanodine Receptor 1-Related Myopathies: Diagnostic and Therapeutic Approaches. Neurotherapeutics. 2018;15:885-99. doi: 10.1007/s13311018-00677-1.

- King JO, Denborough MA, Zapf PW. Inheritance of malignant hyperpyrexia. Lancet. 1972;1:365-70. doi: 10.1016/s0140-6736(72)92854-1.

- Wedel DJ. Malignant hyperthermia and neuromuscular disease. Neuromuscul Disord. 1992;2:157-64. doi: 10.1016/0960-8966(92)90001-m.

- Shanina E, Smith RG. Electrodiagnostic Evaluation of Myopathy. In: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2022. [accessed Jan 2023] Available from: https://www.ncbi.nlm.nih.gov/books/NBK564383/

- Wu S, Ibarra MC, Malicdan MC, Murayama K, Ichihara Y, Kikuchi H, et al. Central core disease is due to RYR1 mutations in more than 90% of patients. Brain. 2006;129:1470-80. doi: 10.1093/brain/awl077.

Downloads

Published

2023-10-18

How to Cite

1.
Vasco J, Viveiros E, Pires P. King-Denborough Syndrome: Report of a Family. Sinapse [Internet]. 2023 Oct. 18 [cited 2024 Nov. 26];23(3):157-60. Available from: https://sinapse.pt/index.php/journal/article/view/14

Issue

Section

Case Reports